Multiparametric magnetic resonance imaging of prostate cancer.

Detection of Prostate Cancer: Quantitative Multiparametric MR Imaging Models Developed Using Registered Correlative Histopathology. Radiology (2016) 0.80

Multiparametric magnetic resonance imaging of prostate cancer. Indian J Radiol Imaging (2013) 0.75

Accuracy of Diffusion Weighted Images and MR Spectroscopy in Prostate Lesions - Our Experience with Endorectal Coil on 1.5 T MRI. J Clin Diagn Res (2017) 0.75

Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev (2010) 12.60

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09

NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A (1982) 4.95

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol (2010) 4.45

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol (1988) 3.20

Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol (2007) 3.12

Imaging prostate cancer: a multidisciplinary perspective. Radiology (2007) 2.79

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol (2008) 2.76

Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol (2004) 2.50

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology (2006) 2.40

Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology (1999) 2.32

Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol (2004) 1.98

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol (2007) 1.92

Prostate cancer imaging. Acta Radiol (2008) 1.82

A clinically relevant approach to imaging prostate cancer: review. AJR Am J Roentgenol (2011) 1.71

Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol (1997) 1.68

Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.66

Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology (2004) 1.58

Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol (2010) 1.51

Functional MR imaging of prostate cancer. Radiographics (2007) 1.48

Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology (1997) 1.43

Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol (2006) 1.40

Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics (2004) 1.29

Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. Radiology (2008) 1.28

Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol (2008) 1.26

Dynamic contrast-enhanced MRI for prostate cancer localization. Br J Radiol (2009) 1.26

Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology (2004) 1.21

Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol (2008) 1.20

Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging (2004) 1.18

Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J Magn Reson Imaging (2009) 1.17

Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol (2008) 1.17

Imaging of the seminal vesicle and vas deferens. Radiographics (2009) 1.15

Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology (2006) 1.14

Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging. Curr Urol Rep (2010) 1.11

Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2004) 1.10

Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography. Curr Opin Urol (2009) 1.06

Multidisciplinary functional MR imaging for prostate cancer. Korean J Radiol (2009) 1.04

Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. J Magn Reson Imaging (2008) 1.03

Diffusion and perfusion MR imaging of the prostate. Magn Reson Imaging Clin N Am (2008) 0.99

New horizons in prostate cancer imaging. Eur J Radiol (2008) 0.99

Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging (2005) 0.99

Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results. J Magn Reson Imaging (2008) 0.97

Radiologic anatomy of the prostate gland: a clinical approach. Radiol Clin North Am (2000) 0.96

Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology (2010) 0.96

Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging. Eur Radiol (2001) 0.94

Diffusion/perfusion MR imaging of the brain: from structure to function. Radiology (1990) 0.92

Combination of signal intensity measurements of lesions in the peripheral zone of prostate with MRI and serum PSA level for differentiating benign disease from prostate cancer. Eur Radiol (2000) 0.88

The prostate: diagnostic evaluation of metastatic disease. Radiol Clin North Am (2000) 0.86

Age-related changes of the prostate: evaluation by MR imaging. AJR Am J Roentgenol (1989) 0.83

Value of 3-T magnetic resonance imaging in local staging of prostate cancer. Top Magn Reson Imaging (2008) 0.83

Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging. World J Radiol (2010) 0.80

Senile amyloidosis of the seminal vesicles mimicking metastatic spread of prostatic carcinoma on MR images. AJR Am J Roentgenol (1993) 0.79

Case records of the Massachusetts General Hospital. Case 35-2012. A 69-year-old chronically ill man with weakness, anorexia, and diffuse pain. N Engl J Med (2012) 3.24

Adult intestinal intussusception: CT appearances and identification of a causative lead point. Radiographics (2006) 3.22

Urine leaks and urinomas: diagnosis and imaging-guided intervention. Radiographics (2003) 2.73

Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation (2008) 1.84

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation (2010) 1.83

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist (2013) 1.76

Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68

Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology (2004) 1.62

Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg (2008) 1.56

Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol (2008) 1.42

ACR Appropriateness Criteria® Multiple gestations. Ultrasound Q (2012) 1.40

Current concepts in lymph node imaging. J Nucl Med (2004) 1.38

ACR Appropriateness Criteria® clinically suspected adnexal mass. Ultrasound Q (2013) 1.38

Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR. Hum Genet (2005) 1.37

Algorithmic approach to CT diagnosis of the abnormal bowel wall. Radiographics (2002) 1.36

Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations. Philos Trans R Soc Lond B Biol Sci (2012) 1.28

Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol (2005) 1.22

Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am J Roentgenol (2011) 1.20

Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol (2002) 1.16

Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation (2010) 1.15

Small bowel CT fat density target sign in chronic radiation enteritis. Australas Radiol (2003) 1.12

Percutaneous imaging-guided abdominal and pelvic abscess drainage in children. Radiographics (2004) 1.10

Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system. PLoS One (2010) 1.09

Measurements of the left common iliac vein diameter may not be consistent over time. J Vasc Interv Radiol (2013) 1.08

Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07

Added value of selected images embedded into radiology reports to referring clinicians. J Am Coll Radiol (2010) 1.05

Adult intestinal intussusception: can abdominal MDCT distinguish an intussusception caused by a lead point? Abdom Imaging (2008) 1.04

Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol (2010) 0.99

Bicuspid aortic valve hemodynamics induces abnormal medial remodeling in the convexity of porcine ascending aortas. Biomech Model Mechanobiol (2014) 0.95

MRI in patients with inflammatory bowel disease. J Magn Reson Imaging (2011) 0.95

Percutaneous radiofrequency ablation of lung tumors: evaluation of the literature using evidence-based techniques. J Thorac Imaging (2011) 0.95

Pulmonary embolism in pregnancy: comparison of pulmonary CT angiography and lung scintigraphy. AJR Am J Roentgenol (2009) 0.95

Is early colonoscopy beneficial in patients with CT-diagnosed diverticulitis? AJR Am J Roentgenol (2013) 0.94

MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation. Cancer Res (2012) 0.93

Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris. Glia (2014) 0.91

Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol (2006) 0.91

ACR appropriateness Criteria® first trimester bleeding. Ultrasound Q (2013) 0.91

Latent Fingerprint Matching: Performance Gain via Feedback from Exemplar Prints. IEEE Trans Pattern Anal Mach Intell (2014) 0.90

Advances in diagnosing and managing antibody-mediated rejection. Pediatr Nephrol (2010) 0.90

MR imaging of malignancies arising in endometriomas and extraovarian endometriosis. Radiographics (2012) 0.89

Let-7a functions as a tumor suppressor in Ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6. DNA Cell Biol (2014) 0.89

Comparison of anterior approach versus posterior approach for the treatment of multilevel cervical spondylotic myelopathy. Eur Spine J (2015) 0.88

The spectrum of IgG4-related disease in the abdomen and pelvis. AJR Am J Roentgenol (2013) 0.88

Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology (2008) 0.88

Postoperative behavior of thoracolumbar/lumbar curve and coronal balance after posterior thoracic fusion for Lenke 1C and 2C adolescent idiopathic scoliosis. J Orthop Sci (2014) 0.87

Overview of nanoparticle use in cancer imaging. Cancer Biomark (2009) 0.87

Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome. Transplantation (2014) 0.87

Imaging of penile neoplasm. Semin Ultrasound CT MR (2007) 0.87

Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy. Transplantation (2011) 0.87

Characterization of the in vitro and in vivo metabolism and disposition and cytochrome P450 inhibition/induction profile of saxagliptin in human. Drug Metab Dispos (2012) 0.86

Segmentation and Enhancement of Latent Fingerprints: A Coarse to Fine Ridge Structure Dictionary. IEEE Trans Pattern Anal Mach Intell (2014) 0.86

ACR appropriateness criteria staging and follow-up of ovarian cancer. J Am Coll Radiol (2013) 0.85

Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin. Clin J Am Soc Nephrol (2011) 0.85

Imaging of penile neoplasms. Radiographics (2005) 0.85

Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases. Int J Radiat Oncol Biol Phys (2008) 0.84

Detection of lymph nodes in pelvic malignancies with Computed Tomography and Magnetic Resonance Imaging. Clin Imaging (2010) 0.83

Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system. Nanomedicine (2013) 0.82

Evaluation of simethicone-coated cellulose as a negative oral contrast agent for abdominal CT. Acad Radiol (2003) 0.82

Case records of the Massachusetts General Hospital. Case 9-2012. A 67-year-old man with a persistently elevated PSA level. N Engl J Med (2012) 0.82

Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices. Abdom Imaging (2014) 0.81

Incidental findings at initial imaging workup of patients with prostate cancer: clinical significance and outcomes. AJR Am J Roentgenol (2012) 0.81

CT and fluoroscopically guided percutaneous embolization treatment of a pseudoaneurysm associated with pancreatitis. J Vasc Interv Radiol (2005) 0.81

Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings. AJR Am J Roentgenol (2013) 0.79

Intermediate cystic renal masses: radiology-pathology correlation. Curr Probl Diagn Radiol (2005) 0.79

Nanoparticle-enhanced MRI to evaluate radiation delivery to the regional lymphatics for patients with breast cancer. Int J Radiat Oncol Biol Phys (2009) 0.79

Image-guided percutaneous biopsy of the adrenal gland: review of indications, technique, and complications. Curr Probl Diagn Radiol (2003) 0.79

Fungus-infected fluid collections in thorax or abdomen: effectiveness of percutaneous catheter drainage. Radiology (2005) 0.79

Lymph node staging in esophageal adenocarcinoma with PET-CT based on a visual analysis and based on metabolic parameters. Abdom Imaging (2009) 0.79

ACR appropriateness Criteria® second and third trimester bleeding. Ultrasound Q (2013) 0.79

Right-sided colonic diverticulitis: CT findings. J Comput Assist Tomogr (2002) 0.79

The relationship of body mass index and abdominal fat on the radiation dose received during routine computed tomographic imaging of the abdomen and pelvis. Can Assoc Radiol J (2011) 0.78

Impact of magnetic resonance enterography in the management of small bowel Crohn's disease. Eur J Gastroenterol Hepatol (2013) 0.78

Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes. World J Cardiol (2012) 0.78

The potential of nanoparticle-enhanced imaging. Urol Oncol (2008) 0.78

New imaging modalities in bladder cancer. World J Urol (2006) 0.78

Pelvic nodal imaging. Radiol Clin North Am (2012) 0.78

Migration insertion polymerization (MIP) of cyclopentadienyldicarbonyldiphenylphosphinopropyliron (FpP): a new concept for main chain metal-containing polymers (MCPs). J Am Chem Soc (2013) 0.78

Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10. Clin Imaging (2010) 0.77

Palpable right breast mass in a pregnant woman. Nat Clin Pract Oncol (2005) 0.77

Radiologic percutaneous gastrostomy: review of potential complications and approach to managing the unexpected outcome. AJR Am J Roentgenol (2013) 0.77

Detection of nodal metastatic disease in patients with non-small cell lung cancer: comparison of positron emission tomography (PET), contrast-enhanced computed tomography (CT), and combined PET-CT. Clin Imaging (2010) 0.77

Preoperative evaluation of perinephric fat invasion in patients with renal cell carcinoma: correlation with pathological findings. Clin Imaging (2012) 0.77

Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model. AJR Am J Roentgenol (2009) 0.77

Multitechnique imaging findings of Prolene plug hernia repair. AJR Am J Roentgenol (2010) 0.76

Impact of virtual cross match on waiting times for heart transplantation. Ann Thorac Surg (2011) 0.76

Molecular imaging in urologic surgery. Urol Clin North Am (2009) 0.76

Treatment of Femoral Head Necrosis With Bone Marrow Mesenchymal Stem Cells Expressing Inducible Hepatocyte Growth Factor. Am J Ther (2015) 0.76

Enhancement characteristics of ultrasmall superparamagnetic iron oxide particle within the prostate gland in patients with primary prostate cancer. J Comput Assist Tomogr (2008) 0.76

The synthesis of a carbon-14 labeled pegylated Adnectin™ for placental transfer studies in guinea pigs. J Labelled Comp Radiopharm (2013) 0.76

Poly[[aqua-(μ(2)-4,4'-bipyridine-κ(2)N:N')[μ(3)-3-bromo-2-(carboxyl-atometh-yl)-benzoato-κ(3)O(1):O(1'):O(2)]cadmium] monohydrate]. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75

Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis. Acad Radiol (2012) 0.75

catena-Poly[[tetra-aqua-nickel(II)]-μ-(9,10-dioxo-9,10-dihydro-anthracene-1,4,5,8-tetra-carboxyl-ato)-κ(2)O(1):O(8)-[tetra-aqua-nickel(II)]-μ-4,4'-bipyridine-κ(2)N:N']. Acta Crystallogr Sect E Struct Rep Online (2012) 0.75

Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activity. Biochem Pharmacol (2012) 0.75

An association of platelet indices with blood pressure in Beijing adults: Applying quadratic inference function for a longitudinal study. Medicine (Baltimore) (2016) 0.75

Anatomic study of individualized and improved pedicle screw implantation in the lower cervical spine. Int Surg (2015) 0.75